• Join
  • Login
  • Contact

Search abstracts

Pharmacokinetics study of irinotecan and sn-38 by coadministered thalidomide

  • At: Lisbon (Portugal) (2010)
  • Type: Poster
  • By: SHI, Aixin (Department of pharmacy,Beijing Hospital, Beijing, China)
  • Co-author(s): Hu, Xin (Department of pharmacy,Beijing Hospital, BEIJING, China)
    Hu, Yanling (Department of pharmacy,Beijing Hospital, BEIJING, China)
  • Abstract:

    BACKGROUND: Irinotecan(CPT-11) is a broad-spectrum antineoplastic agent. The clinical use of CPT-11 is hindered by dose-limiting diarrhea. SN-38 is an active metabolite of CPT-11, delayed diarrhea could be reduced if the concentration of SN-38 was decreased. It has been confirmed the intestinal toxicity of CPT-11 was relieved by coadministrated


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses